Kirin Q3 2025 Earnings Report

Kirin EPS Results

• Actual EPS: $0.42
• Consensus EPS: $0.34
• Beat/Miss: Beat by +$0.08
• One Year Ago EPS: N/A

Kirin Revenue Results

• Actual Revenue: $4.02 billion
• Expected Revenue: $4.16 billion
• Beat/Miss: Missed by -$135.19 million
• YoY Revenue Growth: N/A

Kirin Announcement Details

• Quarter: Q3 2025
• Date: 11/11/2025
• Time: Before Market Opens
• Conference Call Date: N/A
• Conference Call Time: N/A

Kirin (OTCMKTS:KNBWY) Holdings Company, Limited is a Japan-based global beverage and life sciences group best known for its flagship beer brand. The company’s core operations encompass the brewing and distribution of beer and spirits, the production of soft drinks and other non-alcoholic beverages, and a growing pharmaceuticals and biotech segment. Kirin’s beverage portfolio ranges from mainstream lagers and craft-inspired brews to juices, teas, and carbonated soft drinks sold under various regional labels.

Rooted in the founding of Kirin Brewery Company in 1888, the group restructured into a pure holding company in 2007 to foster greater strategic flexibility. Over more than a century of expansion, Kirin has grown beyond Japan to establish a presence across Asia, Oceania, the Americas and Europe. Notable milestones include its majority stake in Australia’s Lion Nathan, partnerships with Chinese soft-drink bottlers, and the 2019 consolidation of its global pharmaceutical operations under Kyowa Kirin Co., Ltd., focusing on oncology, immunology and nephrology therapies.

The company is led by President and CEO Yoshinori Isozaki, who took the helm in April 2021. Under his stewardship, Kirin has emphasized sustainable practices—from water stewardship at its breweries to circular packaging initiatives—and continues to explore growth opportunities in health science through R&D investments. With a diversified business model spanning beverages and life sciences, Kirin Holdings leverages its century-long heritage to pursue innovation and resilience in global markets.